Listed

Evolent Health, Inc.

EVHNYSECIK 1628908IndustrialsFiscal year ends Dec 31

Reports and events: 235 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Evolent Health, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0320:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001628908-23-000169
2023-11-0217:18 ET10-QQuarterly reportPeriod 2023-09-300001628908-23-000165
2023-11-0216:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628908-23-000162
2023-10-1617:35 ET8-K/A9.01 Financial statements and exhibits0001628908-23-000149
2023-09-2617:28 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001628908-23-000141
2023-08-0416:51 ET8-K/A8.01 Other events0001628908-23-000130
2023-08-0318:14 ET10-QQuarterly reportPeriod 2023-06-300001628908-23-000121
2023-08-0216:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001628908-23-000119
2023-07-2616:50 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-23-000115
2023-06-0816:15 ET8-K5.07 Shareholder vote results0001628908-23-000076
2023-05-2308:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-23-000069
2023-05-0419:40 ET10-QQuarterly reportPeriod 2023-03-310001628908-23-000066
2023-05-0316:15 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628908-23-000061
2023-04-2816:06 ETDEF 14AProxy statement0001193125-23-126887
2023-04-1916:12 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-23-000056
2023-03-2916:01 ET8-K1.02 Termination of a material agreement0001628908-23-000051
2023-02-2417:09 ET10-KAnnual reportPeriod 2022-12-310001628908-23-000029
2023-02-2216:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628908-23-000014
2023-02-1516:23 ET8-K8.01 Other events0001628908-23-000010
2023-01-2308:01 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-23-012645
2023-01-1106:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-23-000005
2022-11-1716:04 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-22-000154
2022-11-1020:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-22-000151
2022-11-0316:28 ET10-QQuarterly reportPeriod 2022-09-300001628908-22-000141
2022-11-0216:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628908-22-000138
2022-10-1107:32 ET8-K7.01 Regulation FD disclosure0001628908-22-000134
2022-09-0616:23 ET8-K5.02 Departure or appointment of officers or directors0001628908-22-000129
2022-08-2516:46 ETSC 13D/AOwnership report, active investor, amended0000921895-22-002543
2022-08-1816:05 ET8-K3.02 Unregistered sale of equity0001628908-22-000116
2022-08-1217:40 ET8-K3.02 Unregistered sale of equity0001628908-22-000111
2022-08-0317:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-211393
2022-08-0316:03 ET10-QQuarterly reportPeriod 2022-06-300001628908-22-000098
2022-08-0216:17 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628908-22-000093
2022-07-1117:02 ETSC 13D/AOwnership report, active investor, amended0000921895-22-002211
2022-06-2906:13 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-22-000088
2022-06-0916:28 ET8-K5.07 Shareholder vote results0001628908-22-000067
2022-05-0916:11 ETSC 13D/AOwnership report, active investor, amended0000921895-22-001511
2022-05-0518:10 ET10-QQuarterly reportPeriod 2022-03-310001628908-22-000063
2022-05-0416:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628908-22-000061
2022-04-2916:06 ETDEF 14AProxy statementPeriod 2022-06-090001193125-22-133588
2022-03-0708:01 ET8-K8.01 Other events0001628908-22-000050
2022-02-2417:57 ET10-KAnnual reportPeriod 2021-12-310001628908-22-000027
2022-02-2316:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628908-22-000025
2022-02-1117:06 ET8-K8.01 Other events0001628908-22-000012
2022-01-1107:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-22-000003
2021-11-0517:11 ETSC 13D/AOwnership report, active investor, amended0000921895-21-002536
2021-11-0418:24 ET10-QQuarterly reportPeriod 2021-09-300001628908-21-000149
2021-11-0316:13 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628908-21-000142
2021-10-0416:14 ET8-K3.02 Unregistered sale of equity0001628908-21-000132
2021-08-0519:12 ET10-QQuarterly reportPeriod 2021-06-300001628908-21-000116

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 04:22 ET. Listed shows no prices and gives no investment advice.